2-keto-3-deoxyoctonate has been researched along with ciprofloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gmeiner, J; Kroll, HP; Leying, H; Opferkuch, W; Suerbaum, S | 1 |
| Biot, FV; Bozue, JA; Chance, T; Chua, J; Cote, CK; Demons, S; Halasohoris, S; Kijek, TM; Koroleva, G; Ladner, JT; Lovett, S; Miller, L; Mou, S; Nuss, JE; Palacios, G; Raymond, JL; Toothman, RG; Vietri, NJ; Worsham, PL | 1 |
2 other study(ies) available for 2-keto-3-deoxyoctonate and ciprofloxacin
| Article | Year |
|---|---|
Influence of beta-lactam antibiotics and ciprofloxacin on cell envelope of Escherichia coli.
Topics: Amino Acids; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Capsules; beta-Lactams; Cell Membrane; Ciprofloxacin; Diaminopimelic Acid; Escherichia coli; Lipid Metabolism; Phospholipids; Polysaccharides, Bacterial; Sugar Acids | 1987 |
A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia.
Topics: Animals; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Francisella tularensis; Lipopolysaccharides; Mice; Mutation; Post-Exposure Prophylaxis; Sugar Acids; Tularemia; Virulence | 2017 |